Options in Hypersensitivity Reactions to Chemotherapeutics

Options in Hypersensitivity Reactions to Chemotherapeutics Curr Treat Options Allergy (2018) 5:118–132 DOI 10.1007/s40521-018-0160-x Drug Allergy (MJ Torres Jaén, Section Editor) Options in Hypersensitivity Reactions to Chemotherapeutics Mauro Pagani Address Medical Department ASST di Mantova, Presidio Ospedaliero di Pieve di Coriano, Via Bugatte, 1 Pieve di Coriano, 46024, Mantova, Italy Email: mauro.pagani@asst-mantova.it Published online: 30 January 2018 * Springer International Publishing AG, part of Springer Nature 2018 This article is part of the Topical Collection on Drug Allergy Keywords Chemotherapy hypersensitivity Drug allergy Platinum compound hypersensitivity I I I Taxane hypersensitivity Asparaginase hypersensitivity Desensitization I I Opinion statement Purpose of review Chemotherapeutic drugs still represent a gold standard for the treatment of neoplastic disease. They can induce hypersensitivity reactions and are the third leading cause of fatal drug-induced anaphylaxis in the USA. This article has tried to highlight and summarize the most recent scientific progress concerning risk factors, pathogenesis, diagnosis, and treatment of these reactions. Recent findings Identification of patients at high risk of developing hypersensitivity reactions allows risk stratification to guide clinical decision-making. Therefore, the most recent researches evaluated the possibility to perform risk stratification in case of hypersensitivity reactions to platinum compounds and taxanes. In addition, new data are now available regarding the http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Treatment Options in Allergy Springer Journals

Options in Hypersensitivity Reactions to Chemotherapeutics

Loading next page...
 
/lp/springer_journal/options-in-hypersensitivity-reactions-to-chemotherapeutics-a2hJP2Apre
Publisher
Springer International Publishing
Copyright
Copyright © 2018 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Allergology; General Practice / Family Medicine
eISSN
2196-3053
D.O.I.
10.1007/s40521-018-0160-x
Publisher site
See Article on Publisher Site

Abstract

Curr Treat Options Allergy (2018) 5:118–132 DOI 10.1007/s40521-018-0160-x Drug Allergy (MJ Torres Jaén, Section Editor) Options in Hypersensitivity Reactions to Chemotherapeutics Mauro Pagani Address Medical Department ASST di Mantova, Presidio Ospedaliero di Pieve di Coriano, Via Bugatte, 1 Pieve di Coriano, 46024, Mantova, Italy Email: mauro.pagani@asst-mantova.it Published online: 30 January 2018 * Springer International Publishing AG, part of Springer Nature 2018 This article is part of the Topical Collection on Drug Allergy Keywords Chemotherapy hypersensitivity Drug allergy Platinum compound hypersensitivity I I I Taxane hypersensitivity Asparaginase hypersensitivity Desensitization I I Opinion statement Purpose of review Chemotherapeutic drugs still represent a gold standard for the treatment of neoplastic disease. They can induce hypersensitivity reactions and are the third leading cause of fatal drug-induced anaphylaxis in the USA. This article has tried to highlight and summarize the most recent scientific progress concerning risk factors, pathogenesis, diagnosis, and treatment of these reactions. Recent findings Identification of patients at high risk of developing hypersensitivity reactions allows risk stratification to guide clinical decision-making. Therefore, the most recent researches evaluated the possibility to perform risk stratification in case of hypersensitivity reactions to platinum compounds and taxanes. In addition, new data are now available regarding the

Journal

Current Treatment Options in AllergySpringer Journals

Published: Jan 30, 2018

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial